Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
In the midst of the unceasing COVID-19 pandemic, the identification of immunogenic epitopes in the SARS-CoV-2 spike (S) glycoprotein plays a vital role in the advancement and development of intervention strategies. S is expressed on the exterior of the SARS-CoV-2 virion and contains two subunits, na...
Main Authors: | Kim Tien Ng, Nur Khairiah Mohd-Ismail, Yee-Joo Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/178 |
Similar Items
-
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
by: Priyanka Shah, et al.
Published: (2021-03-01) -
Extensive genetic diversity with novel mutations in spike glycoprotein of severe acute respiratory syndrome coronavirus 2, Bangladesh in late 2020
by: S.Z. Afrin, et al.
Published: (2021-05-01) -
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
by: Debashree Chatterjee, et al.
Published: (2022-01-01) -
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein
by: Maria Alfreda Stincarelli, et al.
Published: (2023-09-01) -
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients
by: Hirai K, et al.
Published: (2024-05-01)